PipelinePharma Logo
PipelinePharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers
Sign in Get started

Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-179 manufacturers

Filters

Filters

Filters , active

Country of origin : China
1 products found

pp-179

Solution for injection

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Comments
Indication: Unresectable melanoma (Phase 3, China); metastatic colorectal cancer (Phase 2/EOP2, US) Clinical stage: Phase 3 (melanoma, China); US EOP2 meeting completed (CRC) Modality: Biological (engineered oncolytic herpes simplex virus type 2, HSV-2) Mechanism / Target: Selectively replicates in tumour cells — direct oncolysis, stimulates danger-associated molecular patterns (DAMPs) and anti-tumour immune priming; HSV-2 naturally more immunogenic than HSV-1-based agents (T-VEC) Route / form: Intratumoral injection Differentiation: World's first oncolytic HSV-2 (vs T-VEC which is HSV-1); potentially stronger innate immune activation; Fast-Track and Orphan designation in US; >270 patients treated with favourable safety; China Breakthrough Therapy
Manufacturer #39197

Clinical-stage oncolytic virus company pioneering HSV-2-based cancer immunotherapy. Develops intratumoral oncolytic agents for melanoma and colorectal cancer with regulatory designations in US and China. Wholly owned in China; actively seeking ex-China development or commercialisation partners.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.